Cite
HARVARD Citation
Aguirre, F. et al. (2020). C3, C5a and anti-acetylcholine receptor antibody as severity biomarkers in myasthenia gravis. Therapeutic advances in neurological disorders. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Aguirre, F. et al. (2020). C3, C5a and anti-acetylcholine receptor antibody as severity biomarkers in myasthenia gravis. Therapeutic advances in neurological disorders. p. . [Online].